Transcriptional regulation of porcine endogenous retroviruses released from porcine and infected human cells by heterotrimeric protein complex NF-Y and impact of immunosuppressive drugs.
Recent studies revealed a significant promoter activity of porcine endogenous retrovirus (PERV) long terminal repeats (LTRs) in different human and mammalian cell lines, which is mediated by a 39-bp repeat located in the U3 region in different numbers, representing an enhancer (G. Scheef, N. Fischer, U. Krach, and R. R. Tönjes, J. Virol. 75:6933-6940, 2001). A statistical transcription factor analysis revealed putative binding sites for the CCAAT-binding transcription factor NF-Y inside the 39-bp repeat. Specific binding of NF-Y to the repeat sequence was demonstrated by electrophoretic mobility shift assays and supershift assays with specific antibodies directed against the three subunits of NF-Y. To identify further transcription-regulating elements, genetically modified LTRs lacking the repeat box, U3, R, or U5 were investigated. The results indicated a strong inhibitory element in the R region, as the deletion of R caused a significantly increased promoter activity. Since PERV might play a potential role in the application of xenogeneic cell therapy and xenotransplantation techniques, we have investigated whether immunosuppressive drugs that are routinely used in transplantation medicine have an impact on the promoter activity. Neither cyclosporine nor prednisolone had any influence on the promoter strength of the PERV LTRs. By performing a real-time PCR we were able to compare the proviral loads of porcine and infected human cells as well as the amount of released virions, which revealed a direct link between LTR activity and the number of released retroviruses.
Scheef
Gregor
G
Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany.
Fischer
Nicole
N
Flory
Egbert
E
Schmitt
Isabel
I
Tönjes
Ralf R
RR
D000818:Animals; D023081:CCAAT-Binding Factor / Q000502:physiology*; D002460:Cell Line; D020077:Endogenous Retroviruses / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D011401:Promoter Regions, Genetic; D011533:Proviruses / Q000502:physiology; D013552:Swine / Q000821:virology*; D020079:Terminal Repeat Sequences; D014157:Transcription Factors / Q000378:metabolism; D014158:Transcription, Genetic; D014771:Virion / Q000502:physiology
D023081:CCAAT-Binding Factor; D007166:Immunosuppressive Agents; D014157:Transcription Factors